U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205523) titled 'High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)' on Sept. 12.
Brief Summary: The High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) study is the first prospective real-world cohort of hematologic diseases and transplantation in the Qinghai-Tibet Plateau. Patients undergoing hematopoietic stem cell transplantation (HSCT) at Qinghai University Affiliated Hospital, together with their donors, are systematically enrolled. The registry collects demographic, diagnostic, treatment, prognosis, and medical expense information, as well as biospecimens for future analyses. Historical data are inc...